CKD Bio (XKRX:063160) LT-Debt-to-Total-Asset : 0.22 (As of Jun. 2024)

View and export this data going back to 2001. Start your Free Trial

What is CKD Bio LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. CKD Bio's long-term debt to total assests ratio for the quarter that ended in Jun. 2024 was 0.22.

CKD Bio's long-term debt to total assets ratio increased from Jun. 2023 (0.22) to Jun. 2024 (0.22). It may suggest that CKD Bio is progressively becoming more dependent on debt to grow their business.

CKD Bio LT-Debt-to-Total-Asset Historical Data

The historical data trend for CKD Bio's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CKD Bio LT-Debt-to-Total-Asset Chart

CKD Bio Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

LT-Debt-to-Total-Asset

Get a 7-Day Free Trial

0.09

0.21

0.30

0.26

0.24

CKD Bio Quarterly Data
	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24
LT-Debt-to-Total-Asset	Get a 7-Day Free Trial															0.22	0.31	0.24	0.23	0.22

CKD Bio LT-Debt-to-Total-Asset Calculation

CKD Bio's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

LT Debt to Total Assets (A: Dec. 2023 )	=	Long-Term Debt & Capital Lease Obligation (A: Dec. 2023 )	/	Total Assets (A: Dec. 2023 )
	=	70423.418	/	293785.061
	=	0.24

CKD Bio's Long-Term Debt to Total Asset Ratio for the quarter that ended in Jun. 2024 is calculated as

LT Debt to Total Assets (Q: Jun. 2024 )	=	Long-Term Debt & Capital Lease Obligation (Q: Jun. 2024 )	/	Total Assets (Q: Jun. 2024 )
	=	64751.923	/	297485.636
	=	0.22

CKD Bio (XKRX:063160) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

CKD Bio LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of CKD Bio's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

CKD Bio Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » CKD Bio Corp (XKRX:063160) » Definitions » LT-Debt-to-Total-Asset

Traded in Other Exchanges

N/A

Address

368 Chungjeongno 3-ga, Seodaemun-gu, Seoul, KOR, 120-756

Website

http://www.ckdbio.com

CKD Bio Corp is engaged in manufacturing and distribution of pharmaceutical materials and medicines. Its products portfolio include antibiotic, lactamase inhibitors, antituberculosis, antidiabetics, immunosuppressants, antihyperlipidemics, intermediates, and probiotics.

CKD Bio Headlines

No Headlines